treating health care provider.
(ii) Carefully considered all other treatment
options approved by the United States Food and Drug
Administration.
(iii) Been unable to participate in a clinical trial
for the terminal illness that is located within 100 miles
of the patient's home address or has not been accepted to
the clinical trial within one week of completion of the
clinical trial application process.
(iv) Received a recommendation from the patient's
treating health care provider for an investigational
drug, biological product or device.
(v) A parent or legal guardian who has given
written, informed consent on the patient's behalf for the
use of the investigational drug, biological product or
device.
(vi) Documentation from the patient's treating
health care provider that the patient meets the
requirements of this paragraph.
(vii) Not yet attained 18 years of age.
(2) The term does not include a person being treated as
an inpatient in a hospital.
"Health care provider." A licensed hospital or health care
facility, medical equipment supplier or person who is licensed,
certified or otherwise regulated to provide health care services
under the laws of this Commonwealth, including a physician,
podiatrist, optometrist, psychologist, physical therapist,
certified nurse practitioner, registered nurse, nurse midwife,
physician's assistant, chiropractor, dentist, pharmacist or an
individual accredited or certified to provide behavioral health
20170SB0572PN0659 - 3 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30